Lotus Pharmaceutical Co., Ltd. (1795)

283.5 TWD

2.16%

Last update Dec 15, 1:24 PM CST

Main market

Day range

283.5

274

287

Previous close

277.5

Open

275

Access this stock data via API

Lotus Pharmaceutical Co., Ltd.

283.50

2.16%

Earnings estimate	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Number of analysts	2	2	2	5
Average estimate	4.16	6.22	17.84	27.34
Low estimate	4.11	5.62	17.68	21.01
High estimate	4.20	6.82	18	31.36
Last year EPS	4.32	5.47	19.35	17.84

Access /earnings_estimate data via our API — starting from the Ultra plan.

Revenue estimate	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Number of Analysts	3	2	2	5
Avg. estimate	5.22B	8.09B	19.42B	31.84B
Low estimate	4.99B	7.91B	19.24B	20.55B
High estimate	5.35B	8.27B	19.60B	35.46B
Last year sales	4.41B	4.73B	18.58B	19.42B
Sales growth	0.18	0.71	0.04	0.64

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS trend	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Current estimate	4.16	6.22	17.84	27.34
7 days ago	6.08	5.19	17.04	27.17
30 days ago	6.10	5.19	18.75	27.17
60 days ago	5.79	5.19	18.44	26.74
90 days ago	5.74	4.07	18.20	18.64

Access /eps_trend data via our API — starting from the Ultra plan.

EPS revisions	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Up last 7 days	0	1	1	1
Up last 30 days	0	1	1	1
Down last 7 days	0	0	0	0
Down last 30 days	2	0	1	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Access /growth_estimates data via our API — starting from the Ultra plan.

Buy

60%

Buy

40%

Strong buy

Access /recommendations data via our API — starting from the Ultra plan.